GL1X · GenesisL1 explorer

Ligand · NHO

NHO · Nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvaline

NHO, Nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvaline (C26 H35 N8 O18 P2 +1, 809.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues…

Component
NHO
Formula
C26 H35 N8 O18 P2 +1
Class
ligand
Structures
2
PDB entries
1

Binding sites

NHO in 2 structures; the first of them:

  • 1Q7G · Homoserine Dehydrogenase in complex with suicide inhibitor complex… · NHO A361 · binds ILE11, GLY12, ALA13, GLY14, VAL15, VAL16, GLY17, ALA39 and 22 more
  • 1Q7G · Homoserine dehydrogenase in complex with suicide inhibitor complex… · NHO A361 · binds ILE11, GLY12, ALA13, GLY14, VAL15, VAL16, GLY17, ALA39 and 22 more

Residues it binds most

GLY 2, ALA 2, THR 2, SER 2, ASN 2, ILE 2, LYS 2, VAL 2, ASP 2, GLU 2 (residue and the binding sites it lines).

Found with

  • NA · Sodium ion

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.